Nedrudi, M., Wolfson, T., Ludwig, D., Fraum, T., Chernyak, V., Kierans, A. S., … Bashir, M. (2020). SERUM AFP AS A DIAGNOSTIC MARKER OF HEPATOCELLULAR CARCINOMA IN LIRADS M LESIONS. In HEPATOLOGY (Vol. 72, pp. 684A-685A).

Nedrudi, Marybeth, Tanya Wolfson, Daniel Ludwig, Tyler Fraum, Victoria Chernyak, Andrea Siobhan Kierans, Lauren M. Burke, et al. “SERUM AFP AS A DIAGNOSTIC MARKER OF HEPATOCELLULAR CARCINOMA IN LIRADS M LESIONS.” In HEPATOLOGY, 72:684A-685A, 2020.

Nedrudi M, Wolfson T, Ludwig D, Fraum T, Chernyak V, Kierans AS, et al. SERUM AFP AS A DIAGNOSTIC MARKER OF HEPATOCELLULAR CARCINOMA IN LIRADS M LESIONS. In: HEPATOLOGY. 2020. p. 684A-685A.

Nedrudi, Marybeth, et al. “SERUM AFP AS A DIAGNOSTIC MARKER OF HEPATOCELLULAR CARCINOMA IN LIRADS M LESIONS.” HEPATOLOGY, vol. 72, 2020, pp. 684A-685A.

Nedrudi M, Wolfson T, Ludwig D, Fraum T, Chernyak V, Kierans AS, Burke LM, McGinty KA, Ha H-I, Mendiratta-Lala M, Ranathunga D, McInnes M, Makkar JS, Fowler K, Oloruntoba O, Gamst A, Cardona DM, Muir AJ, Bashir M. SERUM AFP AS A DIAGNOSTIC MARKER OF HEPATOCELLULAR CARCINOMA IN LIRADS M LESIONS. HEPATOLOGY. 2020. p. 684A-685A.